Catch up on ’All Things Urticaria’ in this podcast series developed by GA²LEN UCARE in collaboration with Medthority. Professor Marcus Maurer, Professor of Dermatology and Allergy at Charité – Universitätsmedizin Berlin, is joined by colleagues for in-depth discussions on the latest research and opinion on the pathogenesis and treatment of urticaria. Medthority received educational funding from the sponsor to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated content. The opinions in this podcast are of the invited faculty, for informational purposes only, and should not be taken as medical advice. Please consult your regional guidelines for clinical practice recommendations in your area. For updates on ’All Things Urticaria’, sign up on Medthority. For more on UCARE/ACARE activities, visit the UCARE and ACARE websites, UCARE 4U, UDAY, CRUSE Control App, and CURE Registry. Episodes 1 – 61: This content has been developed independently of the sponsor, Novartis Pharma AG. Episode 31 and 33: This content has been in collaboration with J. Uriach y Compañía S.A.
Join experts Professor Robert Storey and Dr Marc P Bonaca as they discuss management strategies for patients on antiplatelet therapy This podcast is intended for Healthcare Professionals only
Join our host, Professor Jacob P Thyssen, and expert guests as they discuss emerging therapies for moderate to severe Atopic Dermatitis. This podcast is intended for Healthcare Professionals only.
Dr Borja Mora-Peris and Dr Margherita Bracchi discuss a range of medical and clinical questions related to HIV infection management. This podcast is intended for registered Healthcare Professionals only.
Join Dr Nadia Harbeck and Professor Alessandra Gennari in this podcast series on risk assessment and CDK4/6 inhibitors for the treatment of early breast cancer. This podcast is intended for registered Healthcare Professionals only. Developed by EPG Health for Medthority. This content has been developed independently of the sponsor Eli Lilly, who have had no editorial input into the content. EPG Health received unrestricted educational funding from the sponsor in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.
This content has been developed independently of the sponsor, Novartis Pharma AG, who has had no editorial input into the content. Medthority received educational funding from the sponsor in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content. All opinions expressed in the publication digest podcast series are those of the invited faculty. This content should not be taken as medical advice and is for informational purposes only. Please consult your regional clinical practice guidelines for clinical practice recommendations in your area. Join our expert faculty, Professor Stephen Nicholls, Professor Kausik Ray and Professor Oliver Weingärtner as they discuss recent publications in the context of ASCVD and how these findings can be incorporated into clinical practice. This podcast is intended for Healthcare Professionals only. Please be aware this content is not intended for US based audiences.
Join our host, Dr Carla Nester, and expert guests as they discuss the unmet needs around the diagnosis and treatment of patients with complement mediated kidney diseases. This podcast is intended for Healthcare Professionals only. Please be aware this content is not intended for UK and US based audiences.
Join expert contributors for this podcast series looking at treatment approaches and clinical challenges in venous thromboembolism (VTE), cancer-associated VTE (CAT) and atrial fibrillation (AF). Dr Geoffrey Barnes and guests take on gauging the risk of CAT, and guideline recommendations for VTE and CAT; Professor Gregory Lip and Dr Marco Proietti examine real-world evidence for preventing stroke in people with AF. This podcast is intended for Healthcare Professionals only.
Join our host, Dr Brittany Craiglow, and patient-advocate, Damien Hamber, discuss the unmet needs in alopecia areata (AA) management, and the importance of treatment selection and shared decision-making. Coming soon – Dr Brittany Craiglow will be joined by her friend and colleague, Dr Leila Asfour, to discuss the pathophysiology of AA, and recent advances in how JAK inhibitors can be utilised for long-term management. This content is intended for Healthcare Professionals only. Not intended for UK audiences.
In this 3-episode podcast series, experts Dr Patricia Pozo-Rosich, Professor Peter Goadsby, and Professor Messoud Ashina discuss the unmet needs in migraine management. Here, they touch upon the complex barriers for increasing the clinical use of anti-CGRPs, as well as the importance of properly treating acute migraine. “We can’t lose sight of the fact that migraine attacks are frightening for patients. They need to feel reassured that they can be controlled.” Listen Now. This content is intended for Healthcare Professionals only. Not intended for US audiences.
Join our host Professor Nils Erik Gilhus, and a panel of experts in myasthenia gravis (MG) as they discuss a range of medical and clinical challenges related to the management of MG. Coming soon - Professor Maria Teressa Ferretti will be joined by her friend and MG patient Maya Uccheddu, to discuss patient perspective and the burden of this disease. This content is intended for Healthcare Professionals only. Not intended for US audiences.
Join Dr Thomas Buttgereit and expert guests as they discuss all forms of angioedema and their pathophysiology, burden and management strategies. This podcast series is created by GA²LEN ACARE in collaboration with EPG Health for Medthority. All opinions expressed in the ‘All things Angioedema’ podcast series are those of the invited faculty. This content should not be taken as medical advice and is for informational purposes only. Please consult your regional clinical practice guidelines for clinical practice recommendations in your area. This podcast is intended for registered healthcare professionals only.
Join Professor Peter Taylor and a panel of experts as they discuss anti-tumour necrosis factor (TNF) biosimilars in rheumatic disease, looking at anti-TNF best practice and the impact of biosimilars for patients and healthcare professionals.
